PROVIDER PROFILE · NPI 1043506728

Qiyuan DaiMD

PRACTICEJWCH INSTITUTE, INC.See all providers at this practice →

Internal MedicineLancaster, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

4,124

Beneficiaries

—

Total drug cost

$100K

Distinct drugs

Brand share

13.9%

Top prescribed drugs

Atorvastatin Calcium479 claims

Amlodipine Besylate236 claims

Rosuvastatin Calcium235 claims

Lisinopril215 claims

Losartan Potassium191 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050677

Hospital

REFERRAL NETWORK

Where Qiyuan Dai's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	45	110

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
ANTELOPE VALLEY COMMUNITY CLINIC	123	494
Unilab Corporation Clinical Laboratory · West Hills, CA	52	141
Latara Enterprise Inc. Clinical Laboratory · Pomona, CA	34	106
LANCASTER HOSPITAL CORPORATION	18	63
Advanced Endoscopy And Pain Center Llc Ambulatory Surgical Center · Lancaster, CA	13	16

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history